Jodey Arrington (R-TX)

ETHIC Act

H.R. 3269 · House bill Commerce

A Republican bill with 6 Democratic cosponsors · See all 9 cosponsors

Last activity — Referred to the House Committee on the Judiciary.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The ETHIC Act aims to address patent thickets. It limits the number of patents that can be asserted in an infringement action against certain parties. These parties include those involved with specific drug or biological product applications or those manufacturing and selling them. The bill defines a "Patent Group" based on patents or applications linked through specific disclaimers. Under this rule, a person can assert no more than one patent per Patent Group in a single action.

Yes· 3 of 7

  • Scored +6

    Does this lower the price of prescription medicines?

    Reducing patent thickets can facilitate the entry of generic or biosimilar products, lowering drug costs.

  • Scored +5

    Would households on low incomes be better off under this?

    Lower drug prices through increased competition directly benefit low-income households.

  • Scored +5

    Would retired people be better off under this?

    Lower medication costs are highly beneficial for retirees on fixed incomes.

The opposite

No question was scored the opposite.